AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $204.81, giving the company a market capitalization of 320.99B. It carries a P/E multiple of 30.95 and pays a dividend yield of 1.6%.
On 2026-02-24, AstraZeneca(AZN) stock traded between a low of $204.26 and a high of $207.34. Shares are currently priced at $204.81, which is +0.3% above the low and -1.2% below the high.
AstraZeneca(AZN) shares are trading with a volume of 1.82M, against a daily average of 2.48M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $122.48.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $122.48.
AZN News
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study, titled “A Non-interventional, Observational Qualitative Interview Study of...
AIM ImmunoTech (AIM) announced milestones in the expected timeline for the ongoing Phase 2 clinical study evaluating AIM’s drug Ampligen combined with AstraZene...
AstraZeneca’s (AZN) surovatamig for the treatment of follicular lymphoma wasa granted FDA orphan designation, according to a post to the agency’s website. Publ...
Analyst ratings
81%
of 31 ratingsMore AZN News
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca has withdrawn a planned Phase I/II master protocol called “A Master Protoc...
AstraZeneca ( (GB:AZN) ) has issued an update. AstraZeneca has secured U.S. FDA approval for Calquence (acalabrutinib) in combination with venetoclax as the fi...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca Eyes Hidden COPD Risks in Heart Patients The study, “A Multinational...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study, titled “General Use-Results Study of Calquence Capsules 100 mg in Patients...
The European Medicines Agency has validated the Type II Variation marketing authorization application for Enhertu as a monotherapy for adult patients with HER2...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca is tracking how women in Brazil with advanced hormone-driven, HER2-negativ...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) has completed a mid-stage study called “A Phase IIb Two-Cohort, Rand...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.